Clutton Genevieve, Bridgeman Anne, Reyes-Sandoval Arturo, Hanke Tomas, Dorrell Lucy
a The Jenner Institute Laboratories ; University of Oxford ; Oxford , UK.
Hum Vaccin Immunother. 2015;11(4):1030-5. doi: 10.1080/21645515.2015.1009809.
Viral vector vaccines designed to elicit CD8(+) T cells in non-human primates exert potent control of immunodeficiency virus infections; however, similar approaches have been unsuccessful in humans. Adenoviral vectors elicit potent T cell responses but also induce production of immunosuppressive interleukin-10 (IL-10), which can limit the expansion of T cell responses. We investigated whether inhibiting IL-10 signaling prior to immunization with a candidate adenovirus vectored-HIV-1 vaccine, ChAdV63.HIVconsv, could modulate innate and adaptive immune responses in BALB/c mice. Transient IL-10 receptor blockade led to a modest but significant increase in the total magnitude CD8(+) T cell response to HIVconsv, but did not affect T cell responses to immunodominant epitopes. Anti-IL-10R-treated animals also exhibited greater expression of CD86 on CD11c(+) dendritic cells. Our data support further investigation and optimization of IL-10 blocking strategies to improve the immunogenicity of vaccines based on replication-defective adenoviruses.
旨在在非人灵长类动物中引发CD8(+) T细胞的病毒载体疫苗对免疫缺陷病毒感染具有强大的控制作用;然而,类似的方法在人类中并未成功。腺病毒载体可引发强大的T细胞反应,但也会诱导产生免疫抑制性白细胞介素-10(IL-10),这可能会限制T细胞反应的扩展。我们研究了在用候选腺病毒载体HIV-1疫苗ChAdV63.HIVconsv免疫之前抑制IL-10信号传导是否能调节BALB/c小鼠的先天性和适应性免疫反应。短暂的IL-10受体阻断导致对HIVconsv的CD8(+) T细胞反应总量适度但显著增加,但不影响对免疫显性表位的T细胞反应。抗IL-10R处理的动物在CD11c(+)树突状细胞上也表现出更高的CD86表达。我们的数据支持进一步研究和优化IL-10阻断策略,以提高基于复制缺陷腺病毒的疫苗的免疫原性。